DHSC gives go ahead for boys to receive HPV vaccine

DHSC gives go ahead for boys to receive HPV vaccine

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect...

Home Office gives go ahead to allow cannabis-derived products on prescription

Home Office gives go ahead to allow cannabis-derived products on prescription

July 27 2018 Certain cannabis-derived products will be reclassified as Class 2 medicinal...

New law strengthens punishment for assaulting health sector workers

New law strengthens punishment for assaulting health sector workers

July 27 2018 A new law will increase the possible sentencing of someone who commits common...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

  • DHSC gives go ahead for boys to receive HPV vaccine

    DHSC gives go ahead for boys to receive HPV vaccine

    Friday, 27 July 2018 16:22
  • Home Office gives go ahead to allow cannabis-derived products on prescription

    Home Office gives go ahead to allow cannabis-derived products on prescription

    Friday, 27 July 2018 16:19
  • New law strengthens punishment for assaulting health sector workers

    New law strengthens punishment for assaulting health sector workers

    Friday, 27 July 2018 16:16
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:29
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 13:07

a bee imageApril 17 2018

A manufacturing delay is causing problems around availability of Epipen (Senior) 0.3mg Adrenaline Auto-Injector. 

Mylan, parent company of MEDA Pharmaceuticals, the UK Market authorisation holder, says supply problems will be intermittent, with the next shipment expected to be delivered to its UK distribution partner at the end of April. In the meantime, EpiPen 0.3mg Adrenaline Auto-Injectors may not be available, although supplies of the EpiPen Jr 0.15mg Adrenaline Auto-Injectors are not currently affected.

EpiPen is manufactured by Meridian Medical Technologies, a Pfizer company. 

“Mylan is working closely with Pfizer to manage supply carefully to avoid long-term supply shortages. Pfizer anticipates that production rates will increase over the coming months; however, at this time, cannot commit to a specific time for when the supply constraint will be fully resolved,” a notice on the EpiPen website said.

“We are confident in the safety and efficacy of the EpiPen products being produced at Pfizer’s site and are working closely with them to alleviate the situation and achieve a steady state of supply as expeditiously as possible.”

Mylan has not been able to any specific treatment recommendation to individual patients but does recommend that patients speak to their healthcare provider for appropriate actions to be taken.

The website points out that the expiry date of products is at on the last day of the indicated month, Further information is available from Mylan on 01707 853100.

Links:
EpiPen website 

 

Professional News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...